Company intelligence / Profile preview

Cellseed France

Lyon, Rhône, France

Ownership: Private
Development stage: Other

Overview

CellSeed France S.A.R.L. was a French biotechnology subsidiary of the Japanese company CellSeed Inc., established to develop and commercialize cell sheet regenerative medicine products in Europe. The company focused on cell sheet engineering, a platform technology that allows cultured cells to be harvested as intact sheets without enzymatic treatment. Its primary clinical program was CAOMECS (Cultured Autologous Oral Mucosal Epithelial Cell-Sheet), which entered a Phase 3 clinical trial for the treatment of total limbal stem cell deficiency. CellSeed France was based in Lyon, France, and operated from its founding in 2008 until its anticipated dissolution in 2016.

Therapeutic areas: Ophthalmology
Modalities: Cell therapyBiologic
Industry: Biotech

Partnerships

FGK Clinical Research

Beyond the preview

Go deeper on Cellseed France.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellseed France.

Explore the full profile